Saira Ramasastry
CIK 1547959 · last filed 2026-06-17
Saira Ramasastry is a corporate insider who has filed 93 SEC Form 4 insider transactions across 12 companies since 2012. The most recent filing, for VIR, was dated Jun 29, 2026. Across all open-market trades the lifetime net is −$4.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.20M
12
93
-$4.28M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MIRM | Director | 3,977 | $98.70 | $392.5K | -$2.42M | 15 | 2026-06-17 |
| Sensei Biotherapeutics, Inc. (SNSE) Delisted | Director | — | $13.85 | — | $0 | 1 | 2026-06-16 |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Director | 0 | $21.53 | $0 | -$131.9K | 7 | 2026-04-23 |
| VIR | Director | 22,619 | $8.89 | $201.1K | -$761.1K | 12 | 2025-06-02 |
| Akouos, Inc. (AKUS) Delisted | Director | — | $13.29 | — | $0 | 4 | 2022-12-02 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 35,700 | $0.18 | $6.3K | -$963.8K | 17 | 2022-03-01 |
| 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Director | — | $0.07 | — | $0 | 1 | 2020-05-04 |
| CASSAVA SCIENCES INC (SAVA) Delisted | Director | — | $2.34 | — | $0 | 1 | 2019-12-16 |
| 9 METERS BIOPHARMA, INC. (INNT) Delisted | Director | — | — | — | $0 | 2 | 2019-06-04 |
| CASSAVA SCIENCES INC (PTIE) Delisted | Director | — | — | — | $0 | 11 | 2018-09-18 |
| RPRX | Director | 27,779 | $57.97 | $1.61M | $0 | 4 | 2018-01-31 |
| REPROS THERAPEUTICS INC. (RPRX.Z) Delisted | Director | — | — | — | $0 | 3 | 2015-06-01 |
Recent Filings
93 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-29 | VIR | Notice (144) | −16,000 | -$165.1K | EDGAR |
| 2026-06-17 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2026-06-16 | Sensei Biotherapeutics, Inc. (SNSE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2026-06-02 | MIRM | Mixed | — | -$397.7K | EDGAR |
| 2026-06-01 | MIRM | Notice (144) | −3,977 | -$397.7K | EDGAR |
| 2026-05-18 | MIRM | Mixed | — | -$171.9K | EDGAR |
| 2026-05-15 | MIRM | Notice (144) | −2,000 | -$218.9K | EDGAR |
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Disp (D) | −40,485 | $0 | EDGAR |
| 2026-04-16 | MIRM | Mixed | — | -$146.8K | EDGAR |
| 2026-04-15 | MIRM | Notice (144) | −2,000 | -$193.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.